OM · Outset Medical, Inc. · Documents

$4.32 +0.09 (+2.13%) Play latest call Q3 2026 earnings call transcript

Market Cap

$79.83M

18.87M

Volume · Nov 9 54.32K Avg daily vol (3M) 149.78K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

May 4

Current report 8-K

Financial results

Apr 25

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Apr 25

Proxy statement DEFA14A

Proxy statement

Apr 14

Proxy statement DEF 14A Meeting May 31, 2022

Proxy statement

Apr 14

Proxy statement DEFA14A

Proxy statement

Feb 23

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $102.6M ▲ 105.5% Net loss $131.94M

Feb 16

Earnings call

Q4 2021 earnings call

Feb 16

Current report 8-K

Financial results, Regulation FD disclosure

2021

Nov 4

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $26.32M ▲ 91.3% Net loss $30.47M

Nov 3

Earnings call

Q3 2021 earnings call

Nov 3

Current report 8-K

Financial results

Aug 6

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $25.22M ▲ 114.8% Net loss $30.21M

Aug 5

Current report 8-K Events of Jul 30

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Jul 1

Earnings call

Q2 2021 earnings call

Jul 1

Current report 8-K Events of Jun 28

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Jun 4

Current report 8-K Events of Jun 3

Shareholder vote results

May 24

Current report 8-K Events of May 20

Director or officer change, or executive pay, Regulation FD disclosure

May 24

Proxy statement DEFA14A

Proxy statement

May 6

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $22.92M ▲ 218.7% Net loss $30.03M Diluted EPS -$0.70

May 5

Earnings call

Q1 2021 earnings call

May 5

Current report 8-K

Financial results

Apr 21

Proxy statement DEF 14A Meeting Jun 3, 2021

Proxy statement

Apr 21

Proxy statement DEFA14A

Proxy statement

Apr 13

Current report 8-K Events of Apr 8

Entered into a material agreement, Other events

Apr 6

Current report 8-K

Other events

Apr 6

Registration statement S-1

Registration statement

Mar 24

Current report 8-K Events of Mar 23

Director or officer change, or executive pay, Regulation FD disclosure

Mar 22

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $49.94M ▲ 231.2% Net loss $121.49M

Mar 9

Earnings call

Q4 2020 earnings call

Mar 9

Current report 8-K

Financial results

Feb 22

Current report 8-K

Other events

Jan 12

Current report 8-K Events of Jan 8

Director or officer change, or executive pay, Regulation FD disclosure

2020

Nov 30

Current report 8-K

Other events

Nov 30

Registration statement S-1

Registration statement

Nov 12

Earnings call

Q3 2020 earnings call

Nov 12

Current report 8-K Events of Nov 11

Financial results

Nov 12

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $13.76M ▲ 423.0% Net loss $42.29M

Oct 9

Current report 8-K Events of Oct 6

Director or officer change, or executive pay

Sep 9

Registration statement S-1/A

Registration statement

Aug 21

Registration statement S-1

Registration statement

Showing 101–140 of 140 documents

Key facts CIK 1484612 CUSIP 690145206 13F (30d) 37 filings 25 filers Visit website Investor relations